Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idiotype-pulsed Allogeneic DC Vaccine for Multiple Myeloma
NCT00186316Phase 2Completed
- Sponsor
- Stanford University
- Start
- Apr 2003
- Primary completion
- Apr 2006
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of idiotype-pulsed allogeneic dendritic cells in multiple myeloma (MM), sponsored by Stanford University. Started Apr 2003; status: completed.
02
Drugs
idiotype-pulsed allogeneic dendritic cells
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00186316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00186316.